LW
Therapeutic Areas
Cue Biopharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CUE-101 / CUE-100 Series (representative) | HPV+ Head and Neck Cancer / Solid Tumors | Phase 1/2 |
| Immuno-STAT Autoimmune Program | Autoimmune Disease (undisclosed) | Preclinical |
| Cell Therapy Approach | Solid Tumors | Discovery |